About The Fund:

What is the Fund for Innovation in Cancer Informatics?

The Fund for Innovation in Cancer Informatics (ICI) provides grants to support and test novel bioinformatics applications in cancer. The Fund enables cancer researchers to develop data on the efficacy of their approach that may in turn enable them to obtain additional funding from the National Cancer Institute (NCI), National Science Foundation (NSF), or other research foundations supporting cancer research. ICI grants support investigator-initiated projects for up to 2 years.  Awards may be up to $100,000 per year (direct costs), plus 12% allowable indirect costs.  Two-year grant submissions should include mid-grant milestones (at approximately 12-months) for the purpose of evaluating progress toward overall project goals. These milestones must be achieved in order to qualify for the second year of funding.

About Grant Awards:

Who is eligible for an ICI Award?

Applications must be submitted by a team that includes at least one cancer researcher working in partnership with a bioinformatician, computational biologist, or computer scientist either or both of whom should be junior faculty, postdoctoral investigators, or doctoral candidates at an NCI-designated Cancer Center, Comprehensive Cancer Center, Basic Laboratory Cancer Center, or their associated educational institutions.

Funding will be awarded to a U.S. institution, while work may be accomplished in collaboration with international researchers. Organizations receiving the ICI funds must be currently recognized by the Internal Revenue Service as a public charity under sections 501(c)(3) or 509(a)(1), (2), or (3) of the Internal Revenue Code. When collaborating with international researchers, the U.S. institution must certify that they will handle the funds according to the terms of U.S. laws and the grant. Provided that these requirements are met, there is NO limit to the percentage of the grant that can go toward the work of the international researcher.